Information for transplant programs and OPOs regarding 2019 Novel Coronavirus

Monday, February 10, 2020

The recent outbreak of a novel coronavirus (2019-nCoV) in Wuhan, Hubei Province, China and the finding of infection in many other countries including the United States has led to questions among transplant programs, Organ Procurement Organizations (OPOs) and patients. The Organ Procurement and Transplantation Network (OPTN) strives to provide up-to-date information to answer these questions and to provide guidance as needed. Accordingly, the OPTN Ad Hoc Donor Transmission Advisory Committee (DTAC), American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS), after careful review of information available from the Centers for Disease Control and Prevention (CDC), offers information to transplant programs and OPOs in light of these concerns. Please visit the OPTN website for more information.

The AST's Infectious Disease Community of Practice (IDCOP) developed frequently asked questions sheet to relay information on the current state of 2019-nCoV knowledge after receiving queries from transplant colleagues. Please review the FAQ document for additional information.